IVI 2011 Webcasting - EQUIPO IVI 4th International Congress

IVI was founded in 1990 as the first Spanish medical institution exclusively dedicated to Assisted Human Reproduction Treatments. Over the last 20 years, more than 50,000 births give witness to IVI’s success as the european leader in Reproductive Medicine.

IVI 2011 Webcasting

Thursday, April 7, 2011 :: Auditorium 1

Session 2

How to predict bad prognosis patients F. Broekmans, The Netherlands
What does and does not work in AMA patients? F. Olivennes, France
New alternatives for AMA patients J.A. García-Velasco, Spain

Session 3a

Intramural fibroids and infertility: An update review M. Aboulghar, Egypt
Effect of thin endometrium in ART R. Frydman, France
Importance of high progesterone levels in the follicular phase E. Bosch, Spain
Mild vs. Conventional ovarian stimulation - Pro B. Fauser, The Netherlands
Mild vs. Conventional ovarian stimulation - Con R. Fanchin, France
Mild vs. Conventional ovarian stimulation - Discussion

Session 4a

Uterine anomalies R. Campo, Belgium
Alloimmune factors R. Rai, UK

Friday, April 8, 2011 :: Afternoon Auditorium 1

Session 5

Periconceptional determinants of adult health: what should the Fertility Specialist know? N. Macklon, UK
What can be done to improve our ART outcome: The American and the European experience - European Experience P. Devroey, Belgium

Saturday, April 9, 2011 :: Auditorium 1

Session 6

Identification of viable embryos by non-invasive measurement of amino acids H. Leese, UK
Non-invasive embryo assessment-breakthrough technologies S. Shen, USA
Secretomics of endometrial fluid for non-invassive assessment of endometrial receptivity N. Macklon, UK

Session 7

Massive sequencing and its application in human reproduction D. Ramón, Spain
Epigenetic mechanisms: Possible implications in reproductive biology M. Esteller, Spain